Some researchers have theorized that this combination treatment may be especially helpful in managing the signs and symptoms of aging, as well as aiding in the relief of inflammatory conditions
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
How AOD-9604 compares with related compounds and approved drugs
ActivAMP also energizes immune cells, reducing inflammation and preventing illnesses